胸主动脉腔内修复术后症状性脊髓缺血的挽救治疗
本研究回顾性分析了2011至2020年间943例胸主动脉腔内修复术(TEVAR)中脊髓缺血(SCI)的发生率及挽救治疗(RT)效果。术后SCI发生率为7.8%(74例),永久性截瘫1.5%。神经功能改善见于68.9%(51/74)的患者,新增或增加脑脊液引流与SCI结局改善相关,但无任何干预与改善独立相关。
要点
- TEVAR术后SCI发生率为7.8%,永久性截瘫少见(1.5%)。
- 高龄、慢性阻塞性肺疾病和既往腹主动脉手术是SCI的预测因素。
- 神经功能改善见于68.9%的患者,但无干预与改善独立相关。
核心结论
- TEVAR术后SCI导致的永久性截瘫罕见(1.5%)。
- 高龄合并症患者TEVAR术后SCI风险更高。
- 68.9%的患者经脑脊液引流和多模式挽救治疗后SCI症状改善或缓解,但无任何干预与改善独立相关。
研究设计与样本
- 回顾性审查本三级主动脉中心的TEVAR数据库,纳入2011至2020年间869例患者共943例TEVAR手术,评估SCI发生率及挽救治疗细节。
主要发现
- TEVAR术后SCI发生于7.8%(n=74),永久性截瘫发生率为1.5%。
- 高龄、慢性阻塞性肺疾病和既往腹主动脉手术可预测SCI发生。
- 37例(半数)SCI发作仅导致暂时性瘫痪/轻瘫。
- 术后挽救性放置脑脊液引流管占手术的3.7%(n=35),其预测因素包括较高的美国麻醉医师协会分级、较低的血红蛋白水平、升高的国际标准化比值、双侧髂动脉闭塞、非择期手术以及穿透性动脉粥样硬化性溃疡/壁内血肿指征。
- 最常用的挽救治疗包括紧急放置或增加现有脑脊液引流管的引流量(87.8%)、诱导/允许性高血压(77.0%)、皮质类固醇冲击(36.5%)和纳洛酮输注(33.8%);神经功能改善发生于68.9%(n=51/74)。
关键数值与推荐
- 原文未报告具体的诊断阈值、推荐等级或剂量方案。
临床怎么用
- 作者认为TEVAR中心应具备及时安全放置脑脊液引流管的完善方案,以加强SCI的挽救治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Spinal cord ischemia (SCI) after thoracic endovascular aortic repair (TEVAR) can cause permanent neurologic deficits and poor long-term survival. Targeted treatment of new SCI symptoms after TEVAR (rescue therapy [RT]) might improve/resolve neurologic symptoms but few data characterize the association of specific interventions with SCI outcomes. We evaluated the effectiveness of post-TEVAR RT at our tertiary aortic center. METHODS: Our institutional TEVAR database was reviewed for SCI incidence and details of RT. This included cerebrospinal fluid drainage (CSFD), medical therapy, and optimization of spinal cord oxygen delivery. SCI outcomes were categorized at discharge as paralysis/paraparesis and temporary/permanent. RESULTS: Nine hundred forty-three TEVAR procedures were performed in 869 patients from 2011 to 2020. Post-TEVAR SCI occurred in 7.8% (n = 74) with permanent paraplegia in 1.5%. Older patient age, chronic obstructive pulmonary disease, and previous abdominal aortic surgery were predictive of SCI. Half (n = 37) of SCI episodes resulted in only temporary paralysis/paraparesis. Rescue postoperative cerebrospinal fluid drains were implanted in 3.7% (n = 35) of procedures and was predicted by higher American Society of Anesthesiologists class, lower serum hemoglobin level, elevated international normalized ratio, bilateral iliac artery occlusion, nonelective procedures, and penetrating atherosclerotic ulcer/intramural hematoma indication. The most commonly used RTs were emergent placement of or increased drainage from an existing cerebrospinal fluid drain (87.8%), induced/permissive hypertension (77.0%), corticosteroid bolus (36.5%), and naloxone infusion (33.8%). Neurologic improvement occurred in 68.9% (n = 51/74). New/increased drainage was associated with improved SCI outcome. CONCLUSIONS: Permanent paraplegia from post-TEVAR SCI is rare (1.5%). Older patients with comorbidities carry greater post-TEVAR SCI risk. SCI symptoms improved/resolved with CSFD and multimodal RT in 68.9% of patients, but no intervention was independently associated with improvement. TEVAR centers should have robust protocols for timely and safe CSFD placement to augment RT strategies for SCI.
引用
- Spratt JR, Walker KL, Neal D, et al. Rescue therapy for symptomatic spinal cord ischemia after thoracic endovascular aortic repair. J Thorac Cardiovasc Surg. 2022. PMID: 36509568. doi:10.1016/j.jtcvs.2022.10.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。